| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.53 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.32 | 0.09 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.007 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.009 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 0.007 |